Skip to main content

Targeting Complement Factor 5 in Combination with Vascular Endothelial Growth Factor (VEGF) Inhibition for Neovascular Age Related Macular Degeneration (AMD): Results of a Phase 1 Study

Publication ,  Conference
Cousins, SW
Published in: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
April 1, 2010

Duke Scholars

Published In

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

EISSN

1552-5783

ISSN

0146-0404

Publication Date

April 1, 2010

Volume

51

Issue

13

Publisher

ASSOC RESEARCH VISION OPHTHALMOLOGY INC

Related Subject Headings

  • Ophthalmology & Optometry
  • 3212 Ophthalmology and optometry
  • 11 Medical and Health Sciences
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cousins, S. W. (2010). Targeting Complement Factor 5 in Combination with Vascular Endothelial Growth Factor (VEGF) Inhibition for Neovascular Age Related Macular Degeneration (AMD): Results of a Phase 1 Study. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (Vol. 51). ASSOC RESEARCH VISION OPHTHALMOLOGY INC.
Cousins, S. W. “Targeting Complement Factor 5 in Combination with Vascular Endothelial Growth Factor (VEGF) Inhibition for Neovascular Age Related Macular Degeneration (AMD): Results of a Phase 1 Study.” In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 51. ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2010.
Cousins, S. W. “Targeting Complement Factor 5 in Combination with Vascular Endothelial Growth Factor (VEGF) Inhibition for Neovascular Age Related Macular Degeneration (AMD): Results of a Phase 1 Study.” INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 51, no. 13, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2010.

Published In

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

EISSN

1552-5783

ISSN

0146-0404

Publication Date

April 1, 2010

Volume

51

Issue

13

Publisher

ASSOC RESEARCH VISION OPHTHALMOLOGY INC

Related Subject Headings

  • Ophthalmology & Optometry
  • 3212 Ophthalmology and optometry
  • 11 Medical and Health Sciences
  • 06 Biological Sciences